Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (152)	11/27/2000 1:42:05 PM
From: tuck	Read Replies (1) \| Respond to of 1784

>>As I had originally configured the old "trickle" portfolio, it was reagents/instruments/ilk.<< Indeed, and this new one owns or is looking to own most of the original trickle's components, with the exception of a couple culled. KDUS was withdrawn because trickle wasn't likely to hit its bottom line for a while. And since the same could be said of Iconix, what was MCDE doing in the old version, anyhow? If one sticks solely to reagents/instruments one misses a lot of trickle. Certainly reagents and instrumentation are important trickle categories. And now some of them are starting to look a bit more sanely valued, to the point that buying something like QGENF or BDAL at these levels looks half reasonable. The ultimate goal is to gain understanding of the trickle segment in order that we might all make money from it, right? To identify the key beneficiaries of R & D spending, follow them, and identify good entry and exit points. Right? Thus this trickle is broader & more ambitious in that it tries to find reasonably pure plays on all sorts of trickle. Hopefully it will prove useful to you and others interested in the original version since it aims to follow those stocks, too. Thanks for getting the whole idea started and your contributions. Trying to pick up the ball and run a little further. Cheers, Tuck